| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.748 | 0.005 | 0.748 | Anticonvulsant | 0.554 0.009 DBMET00111 0.523 0.011 DBMET01217 | ||
| 0.686 | 0.004 | 0.706 | Anesthetic general | 0.706 0.003 DBMET00111 0.235 0.057 DBMET01217 0.685 0.004 DBMET01218 | DBMET00111 | |
| 0.614 | 0.017 | 0.747 | Aldehyde oxidase inhibitor | 0.747 0.005 DBMET00111 0.148 0.141 DBMET01217 | DBMET00111 | |
| 0.579 | 0.003 | 0.579 | Nav1.1 sodium channel blocker | 0.506 0.004 DBMET00111 0.322 0.007 DBMET01217 0.231 0.014 DBMET01218 | ||
| 0.563 | 0.003 | 0.563 | Lipocortins synthesis antagonist | 0.52 0.003 DBMET00111 0.452 0.005 DBMET01217 0.433 0.006 DBMET01218 | ||
| 0.548 | 0.008 | 0.548 | Psychostimulant | 0.526 0.009 DBMET00111 0.534 0.009 DBMET01218 | ||
| 0.523 | 0.02 | 0.668 | Spasmolytic | 0.565 0.016 DBMET00111 0.467 0.028 DBMET01217 0.668 0.008 DBMET01218 | DBMET01218 | |
| 0.452 | 0.041 | 0.48 | GABA C receptor rho-3 antagonist | 0.48 0.031 DBMET00111 | DBMET00111 | |
| 0.456 | 0.058 | 0.456 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.335 0.168 DBMET00111 | ||
| 0.401 | 0.007 | 0.401 | Nav1.2 sodium channel blocker | 0.332 0.012 DBMET00111 0.347 0.01 DBMET01217 | ||
| 0.329 | 0.005 | 0.329 | Nav1.6 sodium channel blocker | 0.261 0.008 DBMET00111 | ||
| 0.348 | 0.024 | 0.451 | RNA-directed DNA polymerase inhibitor | 0.378 0.02 DBMET00111 0.451 0.014 DBMET01217 0.299 0.032 DBMET01218 | DBMET01217 | |
| 0.31 | 0.008 | 0.31 | Nav1.3 sodium channel blocker | 0.224 0.018 DBMET00111 | ||
| 0.316 | 0.036 | 0.478 | Cyclic AMP phosphodiesterase inhibitor | 0.326 0.032 DBMET00111 0.478 0.008 DBMET01218 | DBMET01218 | |
| 0.353 | 0.085 | 0.528 | Immunosuppressant | 0.363 0.08 DBMET00111 0.283 0.126 DBMET01217 0.528 0.026 DBMET01218 | DBMET01218 | |
| 0.313 | 0.051 | 0.313 | Cardiotonic | 0.249 0.083 DBMET00111 0.172 0.149 DBMET01218 | ||
| 0.303 | 0.042 | 0.492 | DNA synthesis inhibitor | 0.334 0.034 DBMET00111 0.208 0.111 DBMET01217 0.492 0.014 DBMET01218 | DBMET01218 | |
| 0.328 | 0.071 | 0.61 | Immunostimulant | 0.371 0.058 DBMET00111 0.409 0.047 DBMET01217 0.61 0.015 DBMET01218 | DBMET01218 | |
| 0.263 | 0.012 | 0.263 | Ferrochelatase inhibitor | 0.159 0.034 DBMET00111 | ||
| 0.263 | 0.027 | 0.263 | Tumour necrosis factor antagonist | 0.255 0.029 DBMET00111 | ||
| 0.289 | 0.054 | 0.421 | Superoxide dismutase inhibitor | 0.361 0.034 DBMET00111 0.421 0.023 DBMET01217 | DBMET01217 | |
| 0.284 | 0.054 | 0.409 | Vasodilator | 0.303 0.047 DBMET00111 0.409 0.022 DBMET01218 | DBMET01218 | |
| 0.355 | 0.141 | 0.427 | Caspase 9 stimulant | 0.427 0.095 DBMET00111 0.401 0.11 DBMET01218 | DBMET00111 | |
| 0.306 | 0.094 | 0.316 | Vasodilator, peripheral | 0.316 0.089 DBMET00111 0.295 0.099 DBMET01218 | DBMET00111 | |
| 0.22 | 0.01 | 0.22 | 5 Hydroxytryptamine 7 antagonist | 0.104 0.024 DBMET00111 | ||
| 0.227 | 0.017 | 0.227 | GABA C receptor rho-2 antagonist | 0.218 0.021 DBMET00111 | ||
| 0.27 | 0.063 | 0.27 | 5 Hydroxytryptamine uptake stimulant | 0.262 0.07 DBMET00111 | ||
| 0.254 | 0.048 | 0.407 | Peptidyltransferase inhibitor | 0.276 0.035 DBMET00111 0.163 0.162 DBMET01217 0.407 0.006 DBMET01218 | DBMET01218 | |
| 0.214 | 0.01 | 0.218 | Antineoplastic alkaloid | 0.218 0.009 DBMET00111 0.103 0.046 DBMET01218 | DBMET00111 | |
| 0.247 | 0.044 | 0.265 | Growth hormone agonist | 0.265 0.04 DBMET00111 | DBMET00111 | |
| 0.333 | 0.131 | 0.419 | 5 Hydroxytryptamine release inhibitor | 0.356 0.11 DBMET00111 0.419 0.067 DBMET01218 | DBMET01218 | |
| 0.26 | 0.059 | 0.322 | Tyrosine 3 hydroxylase inhibitor | 0.322 0.024 DBMET00111 | DBMET00111 | |
| 0.213 | 0.014 | 0.26 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.182 0.019 DBMET00111 0.26 0.009 DBMET01218 | DBMET01218 | |
| 0.272 | 0.079 | 0.275 | 5 Hydroxytryptamine release stimulant | 0.275 0.078 DBMET00111 0.17 0.152 DBMET01218 | DBMET00111 | |
| 0.261 | 0.07 | 0.46 | Tumour necrosis factor alpha release inhibitor | 0.255 0.073 DBMET00111 0.198 0.111 DBMET01217 0.46 0.018 DBMET01218 | DBMET01218 | |
| 0.202 | 0.018 | 0.422 | UDP-glucose 4-epimerase inhibitor | 0.226 0.015 DBMET00111 0.422 0.005 DBMET01218 | DBMET01218 | |
| 0.276 | 0.107 | 0.283 | Thyroid hormone antagonist | 0.283 0.102 DBMET00111 | DBMET00111 | |
| 0.276 | 0.108 | 0.463 | Vasodilator, coronary | 0.284 0.102 DBMET00111 0.463 0.021 DBMET01218 | DBMET01218 | |
| 0.264 | 0.115 | 0.604 | Cholesterol antagonist | 0.322 0.078 DBMET00111 0.392 0.051 DBMET01217 0.604 0.018 DBMET01218 | DBMET01218 | |
| 0.173 | 0.026 | 0.173 | GABA receptor agonist | 0.137 0.044 DBMET00111 | ||
| 0.19 | 0.048 | 0.559 | Diuretic | 0.169 0.061 DBMET00111 0.559 0.005 DBMET01217 0.356 0.016 DBMET01218 | DBMET01217 | |
| 0.211 | 0.071 | 0.233 | Nitric-oxide synthase stimulant | 0.233 0.046 DBMET00111 0.228 0.051 DBMET01218 | DBMET00111 | |
| 0.148 | 0.008 | 0.148 | Phosphodiesterase 4C inhibitor | 0.091 0.017 DBMET00111 | ||
| 0.157 | 0.018 | 0.157 | Phosphodiesterase 4D inhibitor | 0.129 0.024 DBMET00111 | ||
| 0.273 | 0.14 | 0.473 | Histamine release inhibitor | 0.363 0.094 DBMET00111 0.231 0.17 DBMET01217 0.473 0.039 DBMET01218 | DBMET01218 | |
| 0.175 | 0.043 | 0.27 | Alpha-N-acetylglucosaminidase inhibitor | 0.154 0.053 DBMET00111 0.27 0.02 DBMET01218 | DBMET01218 | |
| 0.149 | 0.019 | 0.17 | Anabolic | 0.164 0.012 DBMET00111 0.17 0.009 DBMET01217 0.104 0.057 DBMET01218 | DBMET01217 | |
| 0.232 | 0.102 | 0.232 | Gastrin inhibitor | |||
| 0.149 | 0.02 | 0.149 | Electrolyte absorption antagonist | 0.118 0.038 DBMET00111 | ||
| 0.152 | 0.029 | 0.152 | GABA C receptor antagonist | 0.148 0.031 DBMET00111 0.097 0.083 DBMET01217 | ||
| 0.146 | 0.023 | 0.146 | GABA C receptor rho-1 antagonist | 0.131 0.031 DBMET00111 | ||
| 0.177 | 0.058 | 0.177 | Cytidine deaminase inhibitor | 0.124 0.096 DBMET00111 | ||
| 0.144 | 0.026 | 0.144 | DNA directed RNA polymerase inhibitor | 0.112 0.043 DBMET00111 0.085 0.076 DBMET01218 | ||
| 0.134 | 0.02 | 0.143 | Metalloproteinase-9 inhibitor | 0.143 0.017 DBMET00111 0.07 0.056 DBMET01217 | DBMET00111 | |
| 0.146 | 0.033 | 0.168 | Bronchodilator | 0.168 0.026 DBMET00111 | DBMET00111 | |
| 0.221 | 0.108 | 0.221 | 5 Hydroxytryptamine 1E antagonist | 0.209 0.121 DBMET00111 | ||
| 0.134 | 0.024 | 0.143 | Metalloproteinase-2 inhibitor | 0.143 0.021 DBMET00111 0.073 0.061 DBMET01217 | DBMET00111 | |
| 0.279 | 0.175 | 0.4 | Calcium channel L-type activator | 0.4 0.081 DBMET00111 | DBMET00111 | |
| 0.163 | 0.06 | 0.389 | Protein kinase stimulant | 0.219 0.035 DBMET00111 0.389 0.009 DBMET01218 | DBMET01218 | |
| 0.117 | 0.014 | 0.117 | Biliverdin reductase inhibitor | 0.09 0.022 DBMET00111 0.057 0.043 DBMET01218 | ||
| 0.142 | 0.04 | 0.142 | 5 Hydroxytryptamine 3A agonist | 0.122 0.054 DBMET00111 | ||
| 0.14 | 0.038 | 0.14 | GABA C receptor agonist | 0.135 0.041 DBMET00111 | ||
| 0.117 | 0.02 | 0.146 | Glycine receptor antagonist | 0.095 0.037 DBMET00111 0.146 0.008 DBMET01217 0.144 0.009 DBMET01218 | DBMET01217 | |
| 0.118 | 0.023 | 0.118 | HIV-1 reverse transcriptase inhibitor | 0.1 0.031 DBMET00111 0.115 0.024 DBMET01217 | ||
| 0.229 | 0.135 | 0.229 | Ca(v)3.3 blocker | |||
| 0.106 | 0.013 | 0.132 | Androgen agonist | 0.132 0.009 DBMET00111 0.104 0.013 DBMET01217 | DBMET00111 | |
| 0.103 | 0.009 | 0.103 | Phosphodiesterase 1A inhibitor | 0.071 0.023 DBMET00111 | ||
| 0.127 | 0.035 | 0.139 | HIV-1 integrase (Overall Integration) inhibitor | 0.139 0.029 DBMET00111 | DBMET00111 | |
| 0.098 | 0.006 | 0.098 | Guanylate cyclase stimulant | 0.062 0.013 DBMET00111 | ||
| 0.119 | 0.027 | 0.119 | Phosphodiesterase I inhibitor | 0.109 0.035 DBMET00111 | ||
| 0.128 | 0.037 | 0.143 | Acetylcholine release stimulant | 0.098 0.092 DBMET00111 0.143 0.021 DBMET01217 0.105 0.075 DBMET01218 | DBMET01217 | |
| 0.164 | 0.072 | 0.189 | Neurotensin receptor agonist | 0.189 0.041 DBMET00111 | DBMET00111 | |
| 0.133 | 0.043 | 0.199 | Photosensitizer | 0.136 0.041 DBMET00111 0.199 0.013 DBMET01218 | DBMET01218 | |
| 0.1 | 0.015 | 0.123 | NMDA 2C receptor antagonist | 0.123 0.01 DBMET00111 0.101 0.015 DBMET01217 | DBMET00111 | |
| 0.183 | 0.098 | 0.183 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.088 | 0.008 | 0.095 | Dihydroorotate oxidase inhibitor | 0.095 0.005 DBMET00111 0.054 0.039 DBMET01217 | DBMET00111 | |
| 0.113 | 0.033 | 0.221 | NADH dehydrogenase inhibitor | 0.122 0.027 DBMET00111 0.221 0.009 DBMET01218 | DBMET01218 | |
| 0.104 | 0.025 | 0.104 | Matrix metalloproteinase inhibitor | 0.104 0.025 DBMET00111 0.075 0.04 DBMET01217 | ||
| 0.08 | 0.003 | 0.08 | Nicotinic acid receptor 2 antagonist | 0.067 0.003 DBMET00111 | ||
| 0.088 | 0.013 | 0.088 | MDM2 inhibitor | 0.074 0.03 DBMET00111 | ||
| 0.092 | 0.018 | 0.092 | Collagenase 3 inhibitor | 0.078 0.026 DBMET00111 | ||
| 0.223 | 0.148 | 0.649 | Transcription factor NF kappa B inhibitor | 0.317 0.087 DBMET00111 0.649 0.026 DBMET01218 | DBMET01218 | |
| 0.163 | 0.091 | 0.175 | Succinate dehydrogenase inhibitor | 0.175 0.074 DBMET00111 | DBMET00111 | |
| 0.1 | 0.03 | 0.174 | Keratolytic | 0.174 0.011 DBMET00111 | DBMET00111 | |
| 0.091 | 0.021 | 0.091 | Phospholipase D inhibitor | 0.07 0.052 DBMET00111 0.084 0.029 DBMET01217 | ||
| 0.105 | 0.036 | 0.115 | Interleukin 5 antagonist | 0.115 0.027 DBMET00111 0.106 0.035 DBMET01218 | DBMET00111 | |
| 0.077 | 0.007 | 0.103 | Nicotinic acid receptor agonist | 0.103 0.005 DBMET00111 | DBMET00111 | |
| 0.07 | 0.004 | 0.079 | Uridine phosphorylase inhibitor | 0.065 0.005 DBMET00111 0.032 0.016 DBMET01217 0.079 0.004 DBMET01218 | DBMET01218 | |
| 0.142 | 0.077 | 0.163 | Adenylate cyclase stimulant | 0.163 0.044 DBMET00111 0.141 0.078 DBMET01217 | DBMET00111 | |
| 0.084 | 0.018 | 0.115 | NMDA 2A receptor antagonist | 0.115 0.01 DBMET00111 0.055 0.033 DBMET01217 | DBMET00111 | |
| 0.145 | 0.08 | 0.356 | Peroxidase inhibitor | 0.356 0.027 DBMET00111 | DBMET00111 | |
| 0.073 | 0.01 | 0.073 | Thymidine kinase inhibitor | 0.062 0.013 DBMET00111 0.066 0.012 DBMET01217 0.037 0.035 DBMET01218 | ||
| 0.091 | 0.027 | 0.091 | Phosphodiesterase III inhibitor | 0.085 0.032 DBMET00111 | ||
| 0.089 | 0.027 | 0.089 | Neutrophil collagenase inhibitor | 0.087 0.028 DBMET00111 | ||
| 0.086 | 0.023 | 0.086 | Argininosuccinate synthase inhibitor | 0.074 0.028 DBMET00111 | ||
| 0.124 | 0.064 | 0.224 | DNA repair enzyme inhibitor | 0.122 0.068 DBMET00111 0.224 0.006 DBMET01218 | DBMET01218 | |
| 0.073 | 0.013 | 0.073 | Aldosterone antagonist | 0.044 0.04 DBMET00111 | ||
| 0.062 | 0.004 | 0.062 | Guanylate cyclase 1 stimulant | 0.028 0.007 DBMET00111 | ||
| 0.122 | 0.065 | 0.145 | Adenylate cyclase inhibitor | 0.145 0.049 DBMET00111 | DBMET00111 | |
| 0.076 | 0.021 | 0.076 | Matrix metalloproteinase (membrane-type) inhibitor | 0.071 0.024 DBMET00111 0.05 0.046 DBMET01217 | ||
| 0.06 | 0.007 | 0.06 | Kainate receptor agonist | 0.058 0.008 DBMET00111 | ||
| 0.074 | 0.023 | 0.074 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.063 0.032 DBMET00111 0.074 0.023 DBMET01218 | ||
| 0.107 | 0.057 | 0.107 | Adenylate kinase inhibitor | 0.098 0.071 DBMET00111 | ||
| 0.109 | 0.06 | 0.426 | AMP-activated protein kinase stimulant | 0.143 0.033 DBMET00111 0.426 0.004 DBMET01218 | DBMET01218 | |
| 0.06 | 0.011 | 0.071 | Nicotinic acid receptor 2 agonist | 0.071 0.009 DBMET00111 | DBMET00111 | |
| 0.067 | 0.018 | 0.067 | Pregnane X receptor antagonist | 0.066 0.019 DBMET00111 | ||
| 0.202 | 0.154 | 0.218 | Insulysin inhibitor | 0.218 0.131 DBMET00111 | DBMET00111 | |
| 0.164 | 0.118 | 0.221 | Neurotrophic factor enhancer | 0.216 0.062 DBMET00111 0.221 0.058 DBMET01218 | DBMET01218 | |
| 0.143 | 0.097 | 0.163 | Arachidonic acid antagonist | 0.163 0.074 DBMET00111 | DBMET00111 | |
| 0.099 | 0.054 | 0.149 | Phosphodiesterase 6D inhibitor | 0.104 0.045 DBMET00111 0.149 0.01 DBMET01218 | DBMET01218 | |
| 0.136 | 0.091 | 0.136 | Ca2+-transporting ATPase inhibitor | 0.135 0.094 DBMET00111 0.131 0.117 DBMET01218 | ||
| 0.16 | 0.116 | 0.696 | Angiogenesis stimulant | 0.242 0.074 DBMET00111 0.445 0.016 DBMET01217 0.696 0.005 DBMET01218 | DBMET01218 | |
| 0.08 | 0.038 | 0.08 | Glycine receptor agonist | 0.08 0.039 DBMET00111 0.07 0.055 DBMET01218 | ||
| 0.133 | 0.094 | 0.133 | Sphingosine 1-phosphate receptor 5 antagonist | 0.13 0.101 DBMET00111 | ||
| 0.125 | 0.086 | 0.125 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.086 DBMET00111 | ||
| 0.042 | 0.005 | 0.042 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.035 0.007 DBMET00111 0.036 0.006 DBMET01217 0.025 0.023 DBMET01218 | ||
| 0.125 | 0.088 | 0.326 | Lipid peroxidase inhibitor | 0.224 0.033 DBMET00111 0.153 0.067 DBMET01217 0.326 0.016 DBMET01218 | DBMET01218 | |
| 0.065 | 0.029 | 0.069 | Matrix metalloproteinase 1 inhibitor | 0.069 0.026 DBMET00111 | DBMET00111 | |
| 0.047 | 0.011 | 0.047 | Calcitonin gene-related peptide antagonist | |||
| 0.039 | 0.003 | 0.039 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.031 0.004 DBMET00111 | ||
| 0.111 | 0.077 | 0.111 | Acetylcholine muscarinic antagonist | 0.109 0.079 DBMET00111 | ||
| 0.041 | 0.006 | 0.041 | Thymidine phosphorylase inhibitor | 0.035 0.008 DBMET00111 | ||
| 0.095 | 0.061 | 0.122 | Prolactin inhibitor | 0.122 0.037 DBMET00111 | DBMET00111 | |
| 0.052 | 0.018 | 0.052 | Parathyroid hormone antagonist | 0.044 0.035 DBMET00111 | ||
| 0.219 | 0.186 | 0.219 | Calcium channel activator | |||
| 0.066 | 0.035 | 0.066 | Phosphodiesterase 1C inhibitor | 0.06 0.048 DBMET00111 | ||
| 0.075 | 0.044 | 0.176 | Phosphofructokinase-1 inhibitor | 0.086 0.038 DBMET00111 0.176 0.014 DBMET01218 | DBMET01218 | |
| 0.055 | 0.024 | 0.055 | Mineralocorticoid receptor antagonist | 0.047 0.035 DBMET00111 | ||
| 0.036 | 0.007 | 0.036 | DNA polymerase III inhibitor | 0.031 0.013 DBMET00111 | ||
| 0.053 | 0.024 | 0.053 | Adenylate cyclase 1 inhibitor | 0.048 0.029 DBMET00111 | ||
| 0.084 | 0.056 | 0.108 | Estrogen-related receptor beta agonist | 0.108 0.017 DBMET00111 | DBMET00111 | |
| 0.091 | 0.063 | 0.13 | Alcohol dehydrogenase inhibitor | 0.13 0.029 DBMET00111 0.101 0.051 DBMET01218 | DBMET00111 | |
| 0.033 | 0.007 | 0.033 | Acid ceramidase inhibitor | |||
| 0.085 | 0.06 | 0.112 | Androgen antagonist | 0.112 0.038 DBMET00111 | DBMET00111 | |
| 0.04 | 0.016 | 0.04 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.079 | 0.056 | 0.079 | Acetylcholine nicotinic antagonist | |||
| 0.059 | 0.036 | 0.121 | Alcohol oxidase inhibitor | 0.121 0.014 DBMET00111 | DBMET00111 | |
| 0.099 | 0.077 | 0.187 | Cystathionine beta-synthase inhibitor | 0.187 0.028 DBMET00111 0.143 0.044 DBMET01218 | DBMET00111 | |
| 0.133 | 0.112 | 0.161 | CF transmembrane conductance regulator agonist | 0.161 0.059 DBMET00111 | DBMET00111 | |
| 0.09 | 0.07 | 0.09 | Alpha 2d adrenoreceptor antagonist | |||
| 0.14 | 0.12 | 0.14 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.061 | 0.041 | 0.061 | TRPA1 antagonist | |||
| 0.155 | 0.137 | 0.19 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.19 0.081 DBMET00111 | DBMET00111 | |
| 0.059 | 0.041 | 0.065 | Ryanodine receptor antagonist | 0.065 0.026 DBMET00111 | DBMET00111 | |
| 0.072 | 0.054 | 0.101 | Porphobilinogen synthase inhibitor | 0.101 0.035 DBMET00111 | DBMET00111 | |
| 0.085 | 0.068 | 0.241 | Triose-phosphate isomerase inhibitor | 0.08 0.075 DBMET00111 0.241 0.007 DBMET01217 0.147 0.021 DBMET01218 | DBMET01217 | |
| 0.022 | 0.005 | 0.024 | Thyroid hormone alpha agonist | 0.024 0.005 DBMET00111 | DBMET00111 | |
| 0.035 | 0.019 | 0.037 | Protein kinase (CK2) beta inhibitor | 0.037 0.016 DBMET00111 | DBMET00111 | |
| 0.059 | 0.043 | 0.059 | Carbamoyl phosphate synthetase inhibitor | 0.055 0.048 DBMET00111 | ||
| 0.036 | 0.02 | 0.036 | Glucocorticoid antagonist | 0.035 0.021 DBMET00111 | ||
| 0.047 | 0.032 | 0.047 | Thymidylate synthase inhibitor | 0.045 0.035 DBMET00111 | ||
| 0.018 | 0.002 | 0.018 | DNA topoisomerase III inhibitor | 0.012 0.003 DBMET00111 | ||
| 0.039 | 0.025 | 0.039 | Potassium channel Kv1.1 blocker | |||
| 0.06 | 0.047 | 0.06 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.016 | 0.005 | 0.016 | DNA polymerase III polC-type inhibitor | 0.014 0.007 DBMET00111 | ||
| 0.165 | 0.153 | 0.293 | Interleukin agonist | 0.293 0.051 DBMET01218 | DBMET01218 | |
| 0.059 | 0.047 | 0.059 | NMDA receptor glycine site agonist | |||
| 0.034 | 0.024 | 0.034 | Fumarate hydratase inhibitor | 0.03 0.029 DBMET00111 | ||
| 0.033 | 0.024 | 0.069 | Purinergic P2Y2 antagonist | 0.031 0.028 DBMET00111 0.069 0.006 DBMET01217 | DBMET01217 | |
| 0.039 | 0.03 | 0.039 | Nicotinic acid receptor 1 agonist | |||
| 0.056 | 0.047 | 0.056 | Phosphodiesterase 1B inhibitor | |||
| 0.03 | 0.021 | 0.03 | Prostaglandin EP3 antagonist | |||
| 0.095 | 0.086 | 0.138 | DOPA decarboxylase inhibitor | 0.138 0.029 DBMET00111 | DBMET00111 | |
| 0.038 | 0.029 | 0.038 | Membrane dipeptidase inhibitor | |||
| 0.081 | 0.072 | 0.081 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.026 | 0.018 | 0.045 | Thyroid hormone agonist | 0.045 0.005 DBMET00111 0.045 0.005 DBMET01217 | DBMET01217 | |
| 0.064 | 0.055 | 0.064 | Glutamate (mGluR6) antagonist | |||
| 0.061 | 0.054 | 0.061 | Acetylcholine M5 receptor agonist | |||
| 0.097 | 0.09 | 0.167 | DNA polymerase I inhibitor | 0.147 0.051 DBMET00111 0.167 0.041 DBMET01218 | DBMET01218 | |
| 0.063 | 0.056 | 0.063 | Glutamate (mGluR7) antagonist | |||
| 0.024 | 0.018 | 0.028 | Glutamate (mGluR1) agonist | 0.028 0.012 DBMET01217 | DBMET01217 | |
| 0.135 | 0.129 | 0.261 | ATPase inhibitor | 0.14 0.119 DBMET00111 0.261 0.011 DBMET01218 | DBMET01218 | |
| 0.115 | 0.11 | 0.116 | Mannose-6-phosphate isomerase inhibitor | 0.116 0.109 DBMET01218 | DBMET01218 | |
| 0.044 | 0.04 | 0.044 | Phosphodiesterase 6C inhibitor | |||
| 0.075 | 0.072 | 0.123 | NMDA receptor antagonist | 0.123 0.034 DBMET00111 0.1 0.047 DBMET01217 | DBMET00111 | |
| 0.037 | 0.033 | 0.063 | Dopamine D5 agonist | 0.063 0.011 DBMET00111 | DBMET00111 | |
| 0.1 | 0.097 | 0.108 | Interleukin 8 antagonist | 0.108 0.079 DBMET00111 | DBMET00111 | |
| 0.043 | 0.04 | 0.043 | Phosphodiesterase 4A inhibitor | |||
| 0.097 | 0.096 | 0.13 | Microtubule formation inhibitor | 0.13 0.051 DBMET01218 | DBMET01218 | |
| 0.016 | 0.014 | 0.016 | Calcitonin gene-related peptide 1 receptor antagonist | |||
| 0.08 | 0.078 | 0.08 | Bromodomain-containing protein 2 inhibitor | |||
| 0.047 | 0.046 | 0.047 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.023 | 0.022 | 0.023 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.044 | 0.045 | 0.103 | Aldose reductase inhibitor | 0.078 0.024 DBMET00111 0.072 0.026 DBMET01217 0.103 0.017 DBMET01218 | DBMET01218 | |
| 0.062 | 0.064 | 0.177 | Cathepsin G inhibitor | 0.177 0.018 DBMET01217 | DBMET01217 | |
| 0.054 | 0.057 | 0.063 | NMDA receptor agonist | 0.063 0.044 DBMET01217 | DBMET01217 | |
| 0.145 | 0.148 | 0.161 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.161 0.13 DBMET00111 | DBMET00111 | |
| 0.085 | 0.088 | 0.1 | Bile acid receptor antagonist | 0.1 0.05 DBMET00111 0.094 0.063 DBMET01217 | DBMET00111 | |
| 0.081 | 0.085 | 0.147 | Creatine kinase inhibitor | 0.147 0.025 DBMET00111 | DBMET00111 | |
| 0.079 | 0.083 | 0.112 | Aminopeptidase B inhibitor | 0.112 0.057 DBMET01217 | DBMET01217 | |
| 0.128 | 0.133 | 0.141 | Heat shock protein 70 antagonist | 0.137 0.085 DBMET00111 0.141 0.071 DBMET01218 | DBMET01218 | |
| 0.008 | 0.014 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 DBMET01218 | DBMET01218 | |
| 0.005 | 0.014 | 0.011 | Thyroid hormone beta agonist | 0.011 0.005 DBMET00111 | DBMET00111 | |
| 0.069 | 0.08 | 0.08 | Ornithine decarboxylase inhibitor | 0.08 0.068 DBMET00111 | DBMET00111 | |
| 0.087 | 0.098 | 0.115 | Mucolytic | 0.108 0.067 DBMET00111 0.115 0.06 DBMET01218 | DBMET01218 | |
| 0.055 | 0.066 | 0.089 | Phenylalanine 4-hydroxylase inhibitor | 0.089 0.032 DBMET00111 | DBMET00111 | |
| 0.115 | 0.127 | 0.254 | Hexokinase inhibitor | 0.137 0.095 DBMET00111 0.254 0.016 DBMET01218 | DBMET01218 | |
| 0.192 | 0.204 | 0.415 | Interleukin 2 agonist | 0.25 0.118 DBMET00111 0.415 0.023 DBMET01218 | DBMET01218 | |
| 0.063 | 0.077 | 0.077 | GABA aminotransferase inhibitor | 0.077 0.05 DBMET00111 | DBMET00111 | |
| 0.12 | 0.135 | 0.269 | Interferon gamma antagonist | 0.145 0.084 DBMET00111 0.269 0.025 DBMET01218 | DBMET01218 | |
| 0.054 | 0.072 | 0.061 | Interferon inducer | 0.061 0.05 DBMET01218 | DBMET01218 | |
| 0.015 | 0.035 | 0.022 | Glutamate (mGluR1a) agonist | 0.022 0.016 DBMET01217 | DBMET01217 | |
| 0.081 | 0.102 | 0.17 | Estrogen receptor beta antagonist | 0.17 0.013 DBMET00111 | DBMET00111 | |
| 0.089 | 0.111 | 0.101 | TRPA1 agonist | 0.101 0.086 DBMET00111 | DBMET00111 | |
| 0.051 | 0.074 | 0.122 | NMDA 2 receptor antagonist | 0.093 0.035 DBMET00111 0.122 0.023 DBMET01217 | DBMET01217 | |
| 0.055 | 0.079 | 0.082 | Glutamate decarboxylase inhibitor | 0.082 0.042 DBMET00111 | DBMET00111 | |
| 0.105 | 0.13 | 0.12 | Vanilloid 1 agonist | 0.12 0.087 DBMET00111 | DBMET00111 | |
| 0.108 | 0.135 | 0.118 | Sigma receptor agonist | 0.118 0.117 DBMET00111 | DBMET00111 | |
| 0.129 | 0.158 | 0.154 | Phospholipase C inhibitor | 0.152 0.101 DBMET00111 0.154 0.099 DBMET01217 | DBMET01217 | |
| 0.047 | 0.078 | 0.072 | Lipase inhibitor | 0.072 0.052 DBMET00111 | DBMET00111 | |
| 0.026 | 0.058 | 0.038 | Oxytocin agonist | 0.038 0.034 DBMET00111 | DBMET00111 | |
| 0.061 | 0.094 | 0.074 | Interferon agonist | 0.074 0.063 DBMET01218 | DBMET01218 | |
| 0.011 | 0.046 | 0.13 | Estrogen receptor beta agonist | 0.123 0.009 DBMET00111 0.13 0.009 DBMET01217 0.028 0.024 DBMET01218 | DBMET01217 | |
| 0.063 | 0.099 | 0.109 | Opioid antagonist | 0.109 0.042 DBMET00111 | DBMET00111 | |
| 0.031 | 0.067 | 0.102 | Carbonic anhydrase VB inhibitor | 0.102 0.016 DBMET01217 | DBMET01217 | |
| 0.035 | 0.073 | 0.05 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.03 DBMET01218 | DBMET01218 | |
| 0.074 | 0.112 | 0.193 | Xanthine oxidase inhibitor | 0.118 0.048 DBMET00111 0.193 0.021 DBMET01218 | DBMET01218 | |
| 0.009 | 0.051 | 0.09 | Estrogen receptor alpha agonist | 0.09 0.01 DBMET00111 | DBMET00111 | |
| 0.046 | 0.088 | 0.083 | Histidine decarboxylase inhibitor | 0.083 0.041 DBMET00111 | DBMET00111 | |
| 0.045 | 0.089 | 0.068 | Beta adrenoreceptor antagonist | 0.068 0.041 DBMET00111 | DBMET00111 | |
| 0.052 | 0.096 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.036 DBMET00111 | DBMET00111 | |
| 0.059 | 0.103 | 0.095 | Opioid kappa receptor antagonist | 0.095 0.04 DBMET00111 | DBMET00111 | |
| 0.039 | 0.087 | 0.087 | Opioid mu receptor antagonist | 0.087 0.037 DBMET00111 | DBMET00111 | |
| 0.016 | 0.067 | 0.027 | Vanilloid 2 agonist | 0.027 0.014 DBMET01218 | DBMET01218 | |
| 0.012 | 0.064 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.007 DBMET01218 | DBMET01218 | |
| 0.043 | 0.096 | 0.14 | Carbonic anhydrase VA inhibitor | 0.14 0.013 DBMET01217 | DBMET01217 | |
| 0.026 | 0.079 | 0.118 | Leukocyte elastase inhibitor | 0.118 0.008 DBMET01217 | DBMET01217 | |
| 0.037 | 0.09 | 0.116 | Heparanase inhibitor | 0.064 0.017 DBMET01217 0.116 0.003 DBMET01218 | DBMET01218 | |
| 0.047 | 0.1 | 0.08 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.08 0.051 DBMET00111 | DBMET00111 | |
| 0.034 | 0.089 | 0.059 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.059 0.031 DBMET00111 | DBMET00111 | |
| 0.034 | 0.092 | 0.077 | Alpha-mannosidase inhibitor | 0.077 0.012 DBMET01218 | DBMET01218 | |
| 0.074 | 0.133 | 0.184 | Alkylator | 0.184 0.031 DBMET01218 | DBMET01218 | |
| 0.015 | 0.074 | 0.078 | Sodium/glucose cotransporter inhibitor | 0.078 0.004 DBMET01218 | DBMET01218 | |
| 0.065 | 0.125 | 0.271 | Expectorant | 0.271 0.01 DBMET01218 | DBMET01218 | |
| 0.005 | 0.069 | 0.02 | Ileal bile acid transport inhibitor | 0.02 0.009 DBMET01218 | DBMET01218 | |
| 0.092 | 0.157 | 0.259 | Cell wall synthesis inhibitor | 0.222 0.023 DBMET01217 0.259 0.014 DBMET01218 | DBMET01218 | |
| 0.011 | 0.079 | 0.026 | Dopamine D1 agonist | 0.026 0.012 DBMET01217 0.026 0.011 DBMET01218 | DBMET01218 | |
| 0.104 | 0.174 | 0.224 | Melanin inhibitor | 0.149 0.083 DBMET00111 0.224 0.033 DBMET01218 | DBMET01218 | |
| 0.035 | 0.105 | 0.185 | Carbonic anhydrase V inhibitor | 0.185 0.009 DBMET01217 | DBMET01217 | |
| 0.046 | 0.117 | 0.06 | Beta 3 adrenoreceptor antagonist | 0.06 0.056 DBMET00111 | DBMET00111 | |
| 0.007 | 0.078 | 0.149 | Estrone sulfatase inhibitor | 0.149 0.003 DBMET01217 | DBMET01217 | |
| 0.064 | 0.138 | 0.08 | D-Ala-D-Ala ligase inhibitor | 0.08 0.069 DBMET00111 | DBMET00111 | |
| 0.022 | 0.1 | 0.07 | Mannosidase inhibitor | 0.07 0.012 DBMET01218 | DBMET01218 | |
| 0.041 | 0.119 | 0.082 | Adenine nucleotide translocase inhibitor | 0.054 0.043 DBMET00111 0.082 0.008 DBMET01217 0.069 0.016 DBMET01218 | DBMET01217 | |
| 0.076 | 0.156 | 0.105 | Aldehyde dehydrogenase inhibitor | 0.105 0.09 DBMET00111 | DBMET00111 | |
| 0.038 | 0.121 | 0.09 | Na+ K+ transporting ATPase inhibitor | 0.09 0.041 DBMET01218 | DBMET01218 | |
| 0.077 | 0.162 | 0.168 | Estrogen antagonist | 0.168 0.018 DBMET00111 | DBMET00111 | |
| 0.108 | 0.195 | 0.274 | Non-steroidal antiinflammatory agent | 0.274 0.034 DBMET01218 | DBMET01218 | |
| 0.062 | 0.15 | 0.151 | M18 aspartyl aminopeptidase inhibitor | 0.151 0.051 DBMET00111 | DBMET00111 | |
| 0.018 | 0.106 | 0.068 | Phosphorylase inhibitor | 0.068 0.021 DBMET01218 | DBMET01218 | |
| 0.194 | 0.284 | 0.745 | Cyclophilin D inhibitor | 0.261 0.2 DBMET00111 0.319 0.146 DBMET01217 0.745 0.01 DBMET01218 | DBMET01218 | |
| 0.142 | 0.234 | 0.233 | Hypoxia-inducible factor 1 alpha inhibitor | 0.208 0.143 DBMET00111 0.233 0.116 DBMET01218 | DBMET01218 | |
| 0.072 | 0.166 | 0.236 | Cyclooxygenase 3 inhibitor | 0.236 0.01 DBMET01218 | DBMET01218 | |
| 0.094 | 0.19 | 0.122 | Papain-like protease (SARS coronavirus) inhibitor | 0.122 0.077 DBMET00111 | DBMET00111 | |
| 0.057 | 0.157 | 0.077 | MAP kinase kinase 7 inhibitor | 0.077 0.056 DBMET00111 | DBMET00111 | |
| 0.044 | 0.145 | 0.077 | Adrenaline agonist | 0.077 0.062 DBMET00111 | DBMET00111 | |
| 0.039 | 0.142 | 0.07 | Analgesic, opioid | 0.07 0.062 DBMET00111 | DBMET00111 | |
| 0.149 | 0.252 | 0.584 | Antithrombotic | 0.322 0.075 DBMET01217 0.584 0.018 DBMET01218 | DBMET01218 | |
| 0.155 | 0.259 | 0.292 | Sodium/bile acid cotransporter inhibitor | 0.292 0.087 DBMET00111 0.215 0.168 DBMET01217 0.226 0.155 DBMET01218 | DBMET00111 | |
| 0.09 | 0.204 | 0.204 | DNA methyltransferase I inhibitor | 0.204 0.067 DBMET01218 | DBMET01218 | |
| 0.01 | 0.129 | 0.175 | Estrogen agonist | 0.084 0.022 DBMET00111 0.175 0.009 DBMET01217 0.047 0.037 DBMET01218 | DBMET01217 | |
| 0.05 | 0.17 | 0.075 | Estrogen receptor alpha antagonist | 0.075 0.057 DBMET00111 | DBMET00111 | |
| 0.058 | 0.179 | 0.339 | Amylase inhibitor | 0.105 0.092 DBMET00111 0.339 0.014 DBMET01218 | DBMET01218 | |
| 0.016 | 0.142 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 DBMET01217 0.031 0.01 DBMET01218 | DBMET01217 | |
| 0.063 | 0.192 | 0.305 | Thrombolytic | 0.196 0.054 DBMET01217 0.305 0.023 DBMET01218 | DBMET01218 | |
| 0.038 | 0.169 | 0.233 | Monophenol monooxygenase inhibitor | 0.101 0.075 DBMET00111 0.233 0.026 DBMET01218 | DBMET01218 | |
| 0.008 | 0.144 | 0.059 | Sodium/glucose cotransporter 2 inhibitor | 0.059 0.005 DBMET01218 | DBMET01218 | |
| 0.056 | 0.193 | 0.181 | Beta glucuronidase inhibitor | 0.181 0.015 DBMET01218 | DBMET01218 | |
| 0.087 | 0.236 | 0.204 | Interleukin 6 antagonist | 0.204 0.038 DBMET01218 | DBMET01218 | |
| 0.045 | 0.196 | 0.119 | ATPase (Vacuolar H+) inhibitor | 0.119 0.02 DBMET01218 | DBMET01218 | |
| 0.084 | 0.235 | 0.214 | DNA methylase inhibitor | 0.214 0.07 DBMET01218 | DBMET01218 | |
| 0.043 | 0.195 | 0.073 | Chymotrypsin inhibitor | 0.073 0.065 DBMET01217 | DBMET01217 | |
| 0.028 | 0.183 | 0.138 | Carbonic anhydrase XIII inhibitor | 0.138 0.024 DBMET01217 | DBMET01217 | |
| 0.05 | 0.209 | 0.11 | Thioredoxin inhibitor | 0.11 0.038 DBMET01218 | DBMET01218 | |
| 0.138 | 0.303 | 0.412 | Apoptosis antagonist | 0.214 0.162 DBMET00111 0.412 0.035 DBMET01218 | DBMET01218 | |
| 0.08 | 0.248 | 0.316 | Hemostatic | 0.287 0.017 DBMET01217 0.316 0.014 DBMET01218 | DBMET01218 | |
| 0.049 | 0.235 | 0.133 | Transcription factor NF kappa B stimulant | 0.133 0.02 DBMET01218 | DBMET01218 | |
| 0.072 | 0.272 | 0.274 | NOS3 expression enhancer | 0.13 0.097 DBMET00111 0.274 0.022 DBMET01218 | DBMET01218 | |
| 0.072 | 0.288 | 0.238 | Insulin secretagoues | 0.238 0.022 DBMET01218 | DBMET01218 | |
| 0.035 | 0.251 | 0.064 | Lipocortins synthesis agonist | 0.064 0.029 DBMET01218 | DBMET01218 | |
| 0.015 | 0.238 | 0.05 | Neuraminidase (Influenza A) inhibitor | 0.05 0.024 DBMET01218 | DBMET01218 | |
| 0.004 | 0.228 | 0.307 | Cholecystokinin B antagonist | 0.307 0.004 DBMET01217 | DBMET01217 | |
| 0.015 | 0.242 | 0.092 | Elastase inhibitor | 0.092 0.012 DBMET01217 | DBMET01217 | |
| 0.012 | 0.246 | 0.165 | Antineoplastic antibiotic | 0.165 0.028 DBMET01218 | DBMET01218 | |
| 0.014 | 0.251 | 0.693 | Cholecystokinin B agonist | 0.693 0.001 DBMET01217 | DBMET01217 | |
| 0.015 | 0.261 | 0.094 | Protein 50S ribosomal subunit inhibitor | 0.094 0.015 DBMET01218 | DBMET01218 | |
| 0.005 | 0.258 | 0.05 | Dopamine D2 agonist | 0.05 0.027 DBMET01217 | DBMET01217 | |
| 0.005 | 0.262 | 0.32 | Cholecystokinin antagonist | 0.32 0.004 DBMET01217 | DBMET01217 | |
| 0.094 | 0.351 | 0.142 | CC chemokine 6 receptor antagonist | 0.142 0.035 DBMET01218 | DBMET01218 | |
| 0.097 | 0.367 | 0.399 | Immunomodulator | 0.399 0.044 DBMET01218 | DBMET01218 | |
| 0.005 | 0.275 | 0.036 | Factor XI inhibitor | 0.036 0.021 DBMET01217 | DBMET01217 | |
| 0.027 | 0.301 | 0.093 | Mediator release inhibitor | 0.093 0.078 DBMET01218 | DBMET01218 | |
| 0.104 | 0.387 | 0.584 | Antibacterial | 0.276 0.154 DBMET01217 0.584 0.022 DBMET01218 | DBMET01218 | |
| 0.004 | 0.287 | 0.366 | Cholecystokinin A antagonist | 0.366 0.003 DBMET01217 | DBMET01217 | |
| 0.079 | 0.364 | 0.361 | Alpha-glucosidase inhibitor | 0.361 0.131 DBMET01218 | DBMET01218 | |
| 0.022 | 0.318 | 0.19 | Topoisomerase I inhibitor | 0.19 0.029 DBMET01218 | DBMET01218 | |
| 0.047 | 0.356 | 0.123 | Interleukin 4 antagonist | 0.117 0.089 DBMET00111 0.123 0.082 DBMET01218 | DBMET01218 | |
| 0.045 | 0.371 | 0.117 | Farnesoid X receptor antagonist | 0.117 0.112 DBMET00111 | DBMET00111 | |
| 0.004 | 0.348 | 0.743 | Cholecystokinin agonist | 0.743 0.002 DBMET01217 | DBMET01217 | |
| 0.026 | 0.392 | 0.098 | Uric acid excretion stimulant | 0.098 0.054 DBMET01218 | DBMET01218 | |
| 0.052 | 0.419 | 0.375 | Hepatoprotectant | 0.136 0.126 DBMET01217 0.375 0.016 DBMET01218 | DBMET01218 | |
| 0.004 | 0.394 | 0.703 | Cholecystokinin A agonist | 0.703 0.002 DBMET01217 | DBMET01217 | |
| 0.009 | 0.402 | 0.329 | Selectin antagonist | 0.148 0.018 DBMET01217 0.329 0.004 DBMET01218 | DBMET01218 | |
| 0.01 | 0.407 | 0.03 | Estrogen-related receptor beta antagonist | 0.03 0.028 DBMET00111 | DBMET00111 | |
| 0.006 | 0.409 | 0.061 | NMDA 2D receptor antagonist | 0.061 0.005 DBMET01217 | DBMET01217 | |
| 0.043 | 0.454 | 0.525 | Antioxidant | 0.194 0.118 DBMET00111 0.245 0.087 DBMET01217 0.525 0.017 DBMET01218 | DBMET01218 | |
| 0.038 | 0.465 | 0.328 | Nitric oxide antagonist | 0.328 0.035 DBMET01218 | DBMET01218 | |
| 0.011 | 0.439 | 0.113 | CDC25A inhibitor | 0.113 0.022 DBMET01217 | DBMET01217 | |
| 0.041 | 0.469 | 0.099 | Interleukin 12 antagonist | 0.099 0.056 DBMET01218 | DBMET01218 | |
| 0.019 | 0.456 | 0.098 | Cell adhesion molecule inhibitor | 0.098 0.036 DBMET01218 | DBMET01218 | |
| 0.007 | 0.444 | 0.118 | HIV-1 integrase (Strand Transfer) inhibitor | 0.118 0.017 DBMET01217 | DBMET01217 | |
| 0.029 | 0.478 | 0.228 | Hypolipemic | 0.228 0.078 DBMET01218 | DBMET01218 | |
| 0.004 | 0.464 | 0.035 | 1,3-Beta-glucan synthase inhibitor | 0.035 0.006 DBMET01217 | DBMET01217 | |
| 0.008 | 0.469 | 0.117 | Protein-tyrosine phosphatase 1B inhibitor | 0.117 0.065 DBMET01217 | DBMET01217 | |
| 0.007 | 0.468 | 0.138 | HIV-1 integrase (3'-Processing) inhibitor | 0.138 0.015 DBMET01217 | DBMET01217 | |
| 0.03 | 0.491 | 0.244 | Platelet antagonist | 0.244 0.075 DBMET01218 | DBMET01218 | |
| 0.051 | 0.525 | 0.216 | Antiobesity | 0.216 0.191 DBMET01217 | DBMET01217 | |
| 0.012 | 0.488 | 0.068 | Antibiotic Aminoglycoside-like | 0.068 0.006 DBMET01218 | DBMET01218 | |
| 0.027 | 0.508 | 0.194 | Cell adhesion inhibitor | 0.194 0.026 DBMET01218 | DBMET01218 | |
| 0.02 | 0.535 | 0.418 | Anticoagulant | 0.418 0.015 DBMET01217 0.178 0.062 DBMET01218 | DBMET01217 | |
| 0.005 | 0.524 | 0.037 | Protein 30S ribosomal subunit inhibitor | 0.037 0.01 DBMET01218 | DBMET01218 | |
| 0.008 | 0.544 | 0.067 | Neuraminidase (influenza) inhibitor | 0.067 0.04 DBMET01218 | DBMET01218 | |
| 0.021 | 0.559 | 0.461 | Free radical scavenger | 0.168 0.126 DBMET00111 0.461 0.02 DBMET01218 | DBMET01218 | |
| 0.005 | 0.557 | 0.201 | NMDA 2B receptor antagonist | 0.201 0.005 DBMET01217 | DBMET01217 | |
| 0.012 | 0.566 | 0.243 | Protein-tyrosine phosphatase inhibitor | 0.243 0.033 DBMET01217 | DBMET01217 | |
| 0.016 | 0.595 | 0.269 | Dual specificity phosphatase 3 inhibitor | 0.269 0.035 DBMET01217 | DBMET01217 | |
| 0.018 | 0.607 | 0.259 | Dual specificity phosphatase inhibitor | 0.259 0.036 DBMET01217 | DBMET01217 | |
| 0.02 | 0.639 | 0.1 | Nav1.4 sodium channel blocker | 0.1 0.076 DBMET01217 | DBMET01217 | |
| 0.02 | 0.673 | 0.143 | Toll-Like receptor 4 antagonist | 0.143 0.025 DBMET01218 | DBMET01218 | |
| 0.032 | 0.689 | 0.553 | Hypoglycemic | 0.553 0.011 DBMET01218 | DBMET01218 | |
| 0.013 | 0.691 | 0.069 | Factor IXa inhibitor | 0.069 0.021 DBMET01217 0.063 0.024 DBMET01218 | DBMET01217 | |
| 0.019 | 0.732 | 0.315 | Platelet adhesion inhibitor | 0.222 0.06 DBMET01217 0.315 0.029 DBMET01218 | DBMET01218 | |
| 0.006 | 0.723 | 0.077 | Thrombin inhibitor | 0.077 0.046 DBMET01217 | DBMET01217 | |
| 0.008 | 0.73 | 0.085 | Topoisomerase II alpha inhibitor | 0.085 0.049 DBMET01218 | DBMET01218 | |
| 0.009 | 0.736 | 0.067 | Glucose-6-phosphate translocase inhibitor | 0.067 0.018 DBMET01218 | DBMET01218 | |
| 0.014 | 0.785 | 0.193 | Angiogenesis inhibitor | 0.193 0.178 DBMET01217 | DBMET01217 | |
| 0.023 | 0.806 | 0.639 | Antiinflammatory | 0.639 0.043 DBMET01218 | DBMET01218 | |
| 0.006 | 0.789 | 0.138 | Topoisomerase II inhibitor | 0.138 0.055 DBMET01218 | DBMET01218 | |
| 0.017 | 0.823 | 0.432 | Apoptosis agonist | 0.432 0.099 DBMET01218 | DBMET01218 | |
| 0.008 | 0.848 | 0.184 | Multidrug resistance-associated protein 1 inhibitor | 0.184 0.014 DBMET01217 | DBMET01217 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |